RecruitingNot Applicable

Evaluation for NCI Surgery Branch Clinical Research Protocols

United States7,000 participantsStarted 1999-07-11

Plain-language summary

Background: The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This study will allow patients to under screening and evaluation for participation in NC-SB Protocols. Eligibility: Patients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol. Design Patients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

* INCLUSION CRITERIA: Age \>= 18 years. Patient suspected of having, or with biopsy proven, malignant disease. Patient is able to understand and willing to sign a written informed consent document. Patient is being evaluated for treatment on an NCI-SB protocols. EXCLUSION CRITERIA: Women of child-bearing potential who are pregnant or plan to become pregnant because of the potentially dangerous effects of some of the screening procedures (e.g., nuclear medicine or other imaging scans) on the fetus.

What they're measuring

Number of individuals suitable for NCI Surgery Branch clinical research protocols

Timeframe: 25 Years

Frequency of HLA type, gene specific mutations, or expression of neoantigens in malignant tumors

Timeframe: 25 years

Results of screening tests

Timeframe: 25 years

Trial details

NCT IDNCT00001823

SponsorNational Cancer Institute (NCI)

Sponsor typeNIH

Study typeOBSERVATIONAL

Contact for this trial

NCI SB Immunotherapy Recruitment Center

(866) 820-4505 irc@nih.gov